RNA 3' End Functional Ablation for cDNA Specificity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current RNA sequencing techniques face challenges due to biases and artifacts introduced during RNA sample preparation and treatment, which limit the resolution and quantification of RNA sequences.

Innovation Solution

The method involves functionally ablating the 3' RNA ends using an oxidizing agent like sodium periodate, converting 2' and 3' hydroxyls into aldehydes, thereby preventing reverse transcription in the absence of an annealing primer, enhancing the specificity and selectivity of cDNA generation from RNA.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If RNA samples are prepared using conventional techniques, then RNA sequences can be obtained, but biases and artifacts are introduced during preparation and treatment

Engineering Contradiction:
Improveaccuracy of RNA sequencingVSAvoidbiases and artifacts in cDNA generation
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent applies preliminary action by treating RNA with periodate oxidation before reverse transcription to modify 3' ends. This pre-treatment prevents spurious priming and self-priming artifacts during subsequent cDNA synthesis, thereby improving sequencing accuracy while eliminating harmful biases introduced by conventional preparation methods

Inventive Principle:
Principle #10Preliminary action

2Productivity

If reverse transcription is performed without primer annealing, then RNA can be transcribed, but spurious priming and self-priming artifacts occur

Engineering Contradiction:
ImprovecDNA generation efficiencyVSAvoidspecificity of reverse transcription
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent changes the chemical parameter of the RNA 3' end by oxidizing it with periodate to form aldehydes. This parameter change prevents spurious priming and self-priming while maintaining specific primer annealing, thus improving reverse transcription specificity without sacrificing productivity

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If conventional RNA preparation methods are used, then RNA can be processed, but ribosomal RNA interference and low coding sequence enrichment occur

Engineering Contradiction:
Improvetranscript quantification accuracyVSAvoidribosomal RNA interference
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent extracts or removes the harmful 3' end functionality from RNA molecules through periodate oxidation. By converting 3' hydroxyl groups to aldehydes, it eliminates ribosomal RNA interference and enhances coding sequence enrichment, thereby improving transcript quantification accuracy

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach reduces artifacts in cDNA generation, improves the reliability and accuracy of transcript quantification, and increases the specificity and sensitivity of RNA sequencing by reducing ribosomal RNA interference and enriching for coding sequences.

Implementation Method 1

The method involves functionally ablating the 3' RNA ends using an oxidizing agent like sodium periodate, converting 2' and 3' hydroxyls into aldehydes

Methodology Applied
Scientific EffectOxidation: Oxidation

Data Source

PatentUS20250051828A1Methods and systems to functionally ablate 3 prime RNA ends
Publication Date: 2025.02.13 SEATTLE CHILDRENS HOSPITAL (DBA SEATTLE CHILDRENS RES INST)
  • US20250051828A1 patent drawing
  • US20250051828A1 patent drawing
  • US20250051828A1 patent drawing

AI summary

Methods and systems to functionally ablate 3′ end of RNA are described. The functional ablation renders polymerases unable to initiate reverse transcription in the absence of an annealing primer. The methods and systems can be used to enhance the specificity and selectivity of cDNA generation from RNA.